Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

Código QR

Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

Aim: The purpose of this study was to examine the phenotypic and genetic characteristics of patients with type 2 diabetes mellitus (T2DM) with different responses to treatment with metformin (MF) in the Novosibirsk region. Materials and methods: We examined 460 patients with T2DM in the Novosibirsk...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina A. Bondar, Olesya Y. Shabelnikova, Ekaterina A. Sokolova, Olga V. Pyankova, Maksim L. Filipenko
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2016
Materias:	type 2 diabetes mellitus metformin atm (rs11212617). Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/459e2d5b4e0f4957b2b91801208fd9af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Factors associated with abnormal cardio-ankle vascular index in patients with type 2 diabetes and prediabetes
por: Aleksei N. Sumin, et al.
Publicado: (2016)

Lack of association between KCNJ11 (rs5219) and ABCC8 (rs757110) polymorphisms and sulphonylurea treatment response in type 2 diabetes patients in Novosibirsk region
por: Irina Arkad'evna Bondar, et al.
Publicado: (2015)

Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016)

Metformin in patients with ischemic heart disease and type 2 diabetes mellitus: mechanism of action and clinical efficiency
por: Ekaterina Nikodimovna Kravchuk, et al.
Publicado: (2013)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015)

The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
por: Olga Mikhailovna Smirnova
Publicado: (2010)

Genetic framework of type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014)

Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)

Russian Association of Endocrinologists reports commencement of Amaril clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2012)

Prevalence of diabetes in the adult population of Novosibirsk
por: Svetlana V. Mustafina, et al.
Publicado: (2017)

Assessment of carotid intima-media thickness in patients with type 2 diabetes mellitus and arterial hypertension
por: Irina Arkad'evna Bondar', et al.
Publicado: (2014)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011)

Morphological and functional parameters of the heart and vessels in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
por: Irina Arkad'evna Bondar', et al.
Publicado: (2014)

Markers of inflammation in patents with type 2 diabetes and cardiovascular form of diabetic autonomous neuropathy
por: Irina Arkad'evna Bondar', et al.
Publicado: (2009)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009)

Injectable therapy in type 2 diabetes mellitus: strategies to improve therapeutic adherence
por: Olesya Y. Gurova, et al.
Publicado: (2018)

Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012)

Urinary excretion of type IV collagen as an early marker of renal fibrosis in patients with diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011)

Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
por: Ivan Sergeevich Kuznetsov, et al.
Publicado: (2013)

Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2016)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB
por: Alexander Sergeevich Ametov, et al.
Publicado: (2009)

Frequency of type 2 diabetes in family and it’s changes in diabetic patients affected or not affected with cancer
por: Lev Mikhaylovich Berstein, et al.
Publicado: (2015)

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
por: Marina V. Shestakova, et al.
Publicado: (2020)

A randomized, double-blind clinical trial of a herbal formulation (GlycaCare-II) for the management of type 2 diabetes in comparison with metformin
por: Muhammed Majeed, et al.
Publicado: (2021)

Phenotypes of prediabetes: pathogenesis and consequences for prediction and prevention of type 2 diabetes and cardiovascular diseases
por: Norbert Stefan
Publicado: (2019)

Condition of bone tissue in postmenopausal women with type 2 diabetes mellitus of Buryat population
por: Tatiana P. Bardymova, et al.
Publicado: (2019)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
por: Vadim V. Genkel, et al.
Publicado: (2018)

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study)
por: N. A. Demidov, et al.
Publicado: (2021)

Diabetes mellitus type 2 in adults
por: Ivan I. Dedov, et al.
Publicado: (2020)

Characteristics of natural history of diabetes mellitus, manifested after Cushing disease treatment
por: Elena Viktorovna Peretokina, et al.
Publicado: (2012)

Analysis of typical approaches to outpatient management of type 2 diabetes mellitus
por: Irina Evgen'evna Sapozhnikova, et al.
Publicado: (2012)

«DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator
por: Marina V. Shestakova, et al.
Publicado: (2021)